E1: US Response to COVID-19 & Impact on Startups, VC & Public Markets with David Friedberg

David Friedberg’s central argument was that COVID policy was being made with the wrong denominator because large numbers of infections might be asymptomatic. He pushed population-level antibody testing and said private Silicon Valley contacts were already buying unapproved Chinese kits and exploring bulk purchases for university research.

Startup financing was already freezing in real time, forcing founders to treat survival—not growth—as the objective. Jason Calacanis had seen an investor withdraw a commitment and founders cut their own salaries 80% and staff pay 50%, while Friedberg had portfolio companies lose financing offers before closing.

Chamath Palihapitiya argued the venture downturn would deepen because collapsing public markets would force institutional investors to rebalance, pressure VC funds to mark down holdings, and reduce follow-on investment. He therefore considered 18 months of startup runway inadequate and urged companies to secure roughly three years of cash.

The financial crisis was not theoretical for the hosts: Chamath briefly left the recording to deal with market trades and liquidity. He described repo-market dysfunction and repeated margin calls as mechanisms capable of transmitting losses through hedge funds, sovereign funds, foundations and banks, eventually constricting capital throughout the economy.

The hosts opposed rescuing shareholders of companies that had entered the crisis without adequate financial buffers, focusing particularly on airlines’ heavy stock buybacks. Chamath favored wiping out equity and even temporary nationalization, with eventual resale proceeds returning to the Treasury rather than preserving existing owners.

Chamath expected the pandemic to reverse decades of optimization for cheap, just-in-time globalization in favor of national resilience. He argued governments and companies would accept higher costs and lower profits for domestic or diversified supply chains, including potentially moving more Apple production back to the United States.

Friedberg saw America’s inability to deploy tests and treatments rapidly as evidence that healthcare regulation could impose lethal costs through inaction as well as protect against harmful action. He expected broader right-to-try policies and less regulatory friction for diagnostics and drugs, while opposing government-directed pharmaceutical R&D.

For Chamath, quarantine produced a surprisingly personal conclusion: deals, status and possessions suddenly mattered far less than health, family and close friends. He said the group’s weekly poker game had helped him through difficult periods of his life, making the enforced separation from those friendships one of the crisis’s hardest effects.